Ackerman timothy j - direct investment history in Horizon pharma plc

Filed on 2017-01-11 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-17-003368.txt Sec File: edgar/data/1667901/0001209191-17-003368-index.htm

2017-01-10 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 1815 shares at $2.40 remaining shares owned 0

Stock Option Right To Buy Horizon Pharma Plc Hznp exercise price 2.40 has valueitem expiration due date 2023-01-01 underlying security shares 1815 underlying security title Ordinary Shares

f1 the option is fully vested and exercisable.


Filed on 2017-01-11 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-17-003368.txt Sec File: edgar/data/1667901/0001209191-17-003368-index.htm

2017-01-10 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 7860 shares at $7.48 remaining shares owned 0

Stock Option Right To Buy Horizon Pharma Plc Hznp exercise price 7.48 has valueitem expiration due date 2021-09-28 underlying security shares 7860 underlying security title Ordinary Shares

f1 the option is fully vested and exercisable.


Filed on 2017-01-11 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-17-003368.txt Sec File: edgar/data/1667901/0001209191-17-003368-index.htm

2017-01-10 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc bought 1815 shares at $2.40 remaining shares owned 41129

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: M Exercise or conversion of derivative security


Filed on 2017-01-11 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-17-003368.txt Sec File: edgar/data/1667901/0001209191-17-003368-index.htm

2017-01-10 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc bought 7860 shares at $7.48 remaining shares owned 39314

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: M Exercise or conversion of derivative security


Filed on 2016-12-19 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-156000.txt Sec File: edgar/data/1667901/0001209191-16-156000-index.htm

2016-12-16 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc bought 10000 shares at $0.00 remaining shares owned 10000

Restricted Stock Units Horizon Pharma Plc Hznp exercise date 2017-12-16 item expiration due date 2017-12-16 underlying security shares 10000 underlying security title Ordinary Shares

f1 each restricted stock unit represents a contingent right to receive one ordinary share of the issuer.


Filed on 2016-11-08 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-148873.txt Sec File: edgar/data/1667901/0001209191-16-148873-index.htm

2016-11-05 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 2500 shares at $0.00 remaining shares owned 5000

Restricted Stock Units Horizon Pharma Plc Hznp underlying security shares 2500 underlying security title Ordinary Shares

f1 each restricted stock unit represents a contingent right to receive one ordinary share of the issuer.
f3 on november 5, 2014, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.


Filed on 2016-11-08 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-148873.txt Sec File: edgar/data/1667901/0001209191-16-148873-index.htm

2016-11-05 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 778 shares at $15.05 remaining shares owned 31454

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities


Filed on 2016-11-08 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-148873.txt Sec File: edgar/data/1667901/0001209191-16-148873-index.htm

2016-11-05 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc bought 2500 shares remaining shares owned 32232

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: M Exercise or conversion of derivative security

f1 each restricted stock unit represents a contingent right to receive one ordinary share of the issuer.
f2 includes 2,051 ordinary shares of the issuer acquired by the reporting person on june 1, 2016 pursuant to an employee stock purchase program.


Filed on 2016-04-19 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-114941.txt Sec File: edgar/data/1667901/0001209191-16-114941-index.htm

2016-04-14 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc bought 2140 shares at $7.48 remaining shares owned 19821

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: M Exercise or conversion of derivative security


Filed on 2016-04-19 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-114941.txt Sec File: edgar/data/1667901/0001209191-16-114941-index.htm

2016-04-14 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 7860 shares at $2.40 remaining shares owned 1815

Stock Option Right To Buy Horizon Pharma Plc Hznp exercise price 2.40 has valueitem expiration due date 2023-01-01 underlying security shares 7860 underlying security title Ordinary Shares

f2 the option vests and becomes exercisable in 48 equal monthly installments commencing on the month following the date of grant (january 2, 2013).


Filed on 2016-04-19 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-114941.txt Sec File: edgar/data/1667901/0001209191-16-114941-index.htm

2016-04-14 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 2140 shares at $7.48 remaining shares owned 7860

Stock Option Right To Buy Horizon Pharma Plc Hznp exercise price 7.48 has valueitem expiration due date 2021-09-28 underlying security shares 2140 underlying security title Ordinary Shares

f1 the option is fully vested and exercisable.


Filed on 2016-04-19 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-114941.txt Sec File: edgar/data/1667901/0001209191-16-114941-index.htm

2016-04-14 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc bought 7860 shares at $2.40 remaining shares owned 27681

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: M Exercise or conversion of derivative security


Filed on 2016-03-24 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-110487.txt Sec File: edgar/data/1667901/0001209191-16-110487-index.htm

2016-03-23 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 9500 shares at $0.00 remaining shares owned 28500

Restricted Stock Units Horizon Pharma Plc Hznp underlying security shares 9500 underlying security title Ordinary Shares

f1 each restricted stock unit represents a contingent right to receive one ordinary share of the issuer.
f2 on march 23, 2015, the reporting person was granted 38,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.


Filed on 2016-03-24 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-110487.txt Sec File: edgar/data/1667901/0001209191-16-110487-index.htm

2016-03-23 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc sold 2955 shares at $16.32 remaining shares owned 17681

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities


Filed on 2016-03-24 by Ackerman Timothy J. SEC CIK 1667901 Form 4

Accession 0001209191-16-110487.txt Sec File: edgar/data/1667901/0001209191-16-110487-index.htm

2016-03-23 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc bought 9500 shares remaining shares owned 20636

Ordinary Shares Horizon Pharma Plc Hznp Transaction code: M Exercise or conversion of derivative security

f1 each restricted stock unit represents a contingent right to receive one ordinary share of the issuer.


Filed on 2016-03-02 by Ackerman Timothy J. SEC CIK 1667901 Form 3

Accession 0001209191-16-104776.txt Sec File: edgar/data/1667901/0001209191-16-104776-index.htm

2016-02-26 Ackerman Timothy J (CIK 1667901) through Direct (Svp Commercial Operations)

Invested in Horizon Pharma Plc remaining shares owned 11136

Ordinary Shares Horizon Pharma Plc Hznp